Skyward Specialty Insurance’s first quarter results were met with a positive market reaction, reflecting the company’s strong execution and differentiated business model. Management attributed the performance to robust growth in fee-generating premiums, the successful integration of Apollo, and a business mix that is less exposed to cycles affecting the property and casualty (P&C) insurance sector. CEO Andrew Robinson emphasized, “Our portfolio construction is genuinely unique amongst the P&C universe…over 50% of the business is in markets less exposed to the P&C cycles.”
Is now the time to buy SKWD? Find out in our full research report (it’s free for active Edge members).
Skyward Specialty Insurance (SKWD) Q1 CY2026 Highlights:
- Revenue: $475.9 million vs analyst estimates of $424 million (44.8% year-on-year growth, 12.2% beat)
- Adjusted EPS: $1.25 vs analyst estimates of $1.11 (12.3% beat)
- Adjusted Operating Income: $62.08 million (13% margin, 20.7% year-on-year growth)
- Market Capitalization: $1.84 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From Skyward Specialty Insurance’s Q1 Earnings Call
- Matthew John Carletti (Citizens): Asked about the impact of Apollo on growth and margins versus industry peers. CEO Andrew Robinson said niche portfolios and uncorrelated business lines should allow for stable margins and selective growth.
- Analyst (Raymond James): Inquired about managed premium growth and risk of exposure to market-sensitive segments. Robinson explained that fee-driven growth is concentrated in unique, less-cyclical syndicates, and the company is disciplined about where it competes.
- Meyer Shields (KBW): Questioned the persistency of Apollo’s mix and loss ratios. Robinson said mix is more influential than seasonality, with Apollo’s loss ratio likely to be comparable to the U.S. business over a full year.
- Alex Scott (Barclays): Asked about Apollo’s participation in cyber and risks from AI. Robinson said Apollo’s largest cyber exposure is through a special purpose syndicate focused outside traditional markets, and U.S. exposure is minimal.
- Tracy Benguigui (Wolfe Research): Pressed on property exposure alignment between Skyward Specialty Insurance and Apollo. Robinson stressed that both segments are taking disciplined approaches and not writing property business that doesn’t meet return thresholds.
Catalysts in Upcoming Quarters
In upcoming quarters, the StockStory team will be tracking (1) the scaling of fee-based revenue streams as Apollo’s managed premium business expands, (2) growth and profitability in accident and health, credit and surety, and specialty programs, and (3) the company’s ability to maintain underwriting discipline amid softening property and casualty markets. Additional focus will be placed on execution of new specialty initiatives and integration synergies.
Skyward Specialty Insurance currently trades at $45.35, up from $43.84 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).
Our Favorite Stocks Right Now
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum - both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks - FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
